90% of patients treated with new Israeli drug discharged in 5 days

[fncceo]

Profit.

On the other hand, a world without goyim would certainly be a lot easier to live in ... just thinking out loud, only partially serious.

 

[RoshawnMarkwees]

On the other hand, a world without goyim would certainly be a lot easier to live in ... just thinking out loud, only partially serious.

Goyim Lives Matter

 

[fncceo]

Goyim Lives Matter

Yeah ... do they really?

 

[RoshawnMarkwees]

Yeah ... do they really?

Profit

 

[fncceo]

Profit

There is that, balanced against the vast fortunes confiscated over and over from Jews when they got tossed out of a place, or worse.

It's a formula that requires at least some thought.

 

[dblack]

The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.

Damn Jews.

COVID: 90% of patients treated with new Israeli drug discharged in 5 days

The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.

www.jpost.com

Sounds promising. Hope it pans out.

 

[RoshawnMarkwees]

There is that, balanced against the vast fortunes confiscated over and over from Jews when they got tossed out of a place, or worse.

It's a formula that requires at least some thought.

Karma

 

[fncceo]

Karma

Yes, precisely that.

 

[Quasar44]

Weatherman2020
Israel has no drug lol
Israel has the worlds biggest ego problem!!
They feel they have to always prove themselves and it’s embarrassing

 

[Quasar44]

Everything good is made in the USA and few other places

 

[JohnDB]

Everything good is made in the USA and few other places

Anti ballistic missile defense is largely developed in Israel... nobody else has the technology like they do. "Iron Dome" systems have made the Palestinians and others give up on lobbing missiles at them...that's why they whine so much and Israelis are so obnoxious in groups.

Just take the missile defense and use some earplugs. (Made in Taiwan)

 

[badger2]

The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.

Damn Jews.

COVID: 90% of patients treated with new Israeli drug discharged in 5 days

The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover within days.

www.jpost.com

If it is true that SARS-CoV-2’s most ancient ancestor is a pig virus, then we point to the Nile River Valley for origins of Suis and cholangiocarcinoma of the Marburg virus vector fruit-bat, Rousettus aegyptiacus, because this bat also suffers from cholangiocarcinoma and the genus is represented in Yunnan, China, the location of RaTG13, SARS-CoV-2’a closest relative.

Always a poor prognosis with cholangiocarcinoma.

Ap 2021 Italian Intrahepatic Cholangiocarcinoma / CD24

A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient - PubMed

Chemotherapy resistance is a relevant clinical issue in tumor treatment, in particular in biliary tract carcinoma (BTC), for which there are no effective therapies, neither in the first nor in the second line. The development of chemoresistant cell lines as experimental models to investigate the...

pubmed.ncbi.nlm.nih.gov

Jun 2021 Peru: CD24 / Triple-Negative Breast Cancer

Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines - PubMed

Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a...

pubmed.ncbi.nlm.nih.gov

 

[RoshawnMarkwees]

If it is true that SARS-CoV-2’s most ancient ancestor is a pig virus, then we point to the Nile River Valley for origins of Suis and cholangiocarcinoma of the Marburg virus vector fruit-bat, Rousettus aegyptiacus, because this bat also suffers from cholangiocarcinoma and the genus is represented in Yunnan, China, the location of RaTG13, SARS-CoV-2’a closest relative.

Always a poor prognosis with cholangiocarcinoma.

Ap 2021 Italian Intrahepatic Cholangiocarcinoma / CD24

A Novel Multidrug-Resistant Cell Line from an Italian Intrahepatic Cholangiocarcinoma Patient - PubMed

Chemotherapy resistance is a relevant clinical issue in tumor treatment, in particular in biliary tract carcinoma (BTC), for which there are no effective therapies, neither in the first nor in the second line. The development of chemoresistant cell lines as experimental models to investigate the...

pubmed.ncbi.nlm.nih.gov

Jun 2021 Peru: CD24 / Triple-Negative Breast Cancer

Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines - PubMed

Triple-negative breast tumours (TNBTs) make up 15-20% of all breast tumours. There is no treatment for them, and the role that cancer stem cells (CSCs) have in carcinogenesis is still unclear, so finding markers and therapeutic targets in CSC exosomes requires these cells to exist as a...

pubmed.ncbi.nlm.nih.gov

I think it came from a badger or 2.

 

[badger2]

Some consider PRRSV, an arterivirus from pigs, to be the most ancient ancestor of SARS-CoV-2.

’Particularly, the four human coronaviruses, HCOV-229E, -OC43, -NL63 and -HKU1, do not form a compact genetic group but rather interleave with coronaviruses of two major genetic linkages, 1a and 2a, infecting other hosts. Likewise, four pairs of coronaviruses infecting either dogs or one of three bat species, (Chinese horseshoe bats, Leschenault’s rousette bats, and greater horseshoe bats) are considered separated in the coronavirus tree and intertwine with coronaviruses infecting other hosts. This phylogenetic pattern is highly suggestive for (some of) these viruses having originated from other coronaviruses crossing a species barrier. Indeed, HCoV-OC43 may have emerged from BCoV (bovine) adapted to humans approximately 100 years ago, and these viruses seem to have retained their ability to infect the other host....It was speculated that the most recent common ancestor (MRCA) of the Nidovirales may have had a genome size close to that of the contemporary arte3riviruses. In this scenario, the transition from this arterivirus-like nidovirus MRCA to the MRCA of the large nidoviruses may have been accompanied by the acquisition of the otherwise unique ExoN domain and a genome size increase of about 14kb. The correlation between these two events perfectly fits the relationship between the quality of genome copying and genome size, as observed in various biological systems.’
(Gorbalenya AE, Genomics and Evolution of the Nidovirales, in Nidoviruses, ASM Press, 2008, Ch. 2)

 

[badger2]

The report for ExoN that Gorbalenya (The Netherlands) mentions is here:

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage - PubMed

The genome organization and expression strategy of the newly identified severe acute respiratory syndrome coronavirus (SARS-CoV) were predicted using recently published genome sequences. Fourteen putative open reading frames were identified, 12 of which were predicted to be expressed from a...

pubmed.ncbi.nlm.nih.gov

’....The 2B cluster should include the immediate ancestor of SARS-CoV, which may circulate in the field. If close relatives of SARS-CoV were to be identified in animal hosts, the virus would represent the second example of a group 2 coronavirus that may have crossed the animal-human barrier. The first putative case is that of the bovine coronavirus (BCoV) and human coronavirus OC43 (HCoV-OC43), two viruses that are so closely related at the genetic level, that they can be considered the same virus species.’

 

[justoffal]

That's a good thing.

Do they 8 or 10 billion doses?

No but Herbal life does....

 

[badger2]

We next link ebola (linking Rousettus cholangiocarcinoma-Marburg) and old age, for two other members of the PRRSV group of arteriviruses:

Dalgard DW, et al, Combined Simian Hemorrhagic Fever and Ebola Virus Infection in Cynomolgus Monkeys, Lab. Anim. Sci. 42:152-57.

Anderson GW et al, C58 and AKR Mice of All Ages Develop Motor Neuron Disease After Lactate Dehydrogenase-Elevating Virus Infection, But Only If Antiviral Immune Responses Are Blocked by Chemical or Genetic Means or As a Result of Old Age, J. Neurovirol. 1:244-52.

Chinese communists knew well that introducing the masked effects of a porcine virus into the West would be devastating for 600,000+ Americans due to its foreign-ness, and it links to cholangiocarcinoma of the Chinese fruit bat, whose cancer story links to the pigs of the Nile River Valley:

Tokyo, 1987, Swine-Serum-Induced Bile Duct Lesion in Mice

Factors influencing the incidence and severity of swine-serum-induced bile duct lesion in mice - PubMed

The detailed histopathology of the swine-serum (SS)-induced bile duct lesion and some factors influencing the incidence and severity of the lesion were examined. The lesion was expressed as an eosinophilic and proliferative cholangitis affecting almost the full length of the biliary tract. It...

pubmed.ncbi.nlm.nih.gov

’....The SS-induced BDL resembles more closely the spontaneous BDL which is rarely seen in aged mice (Lewis, 1984, Spontaneous Lesions of the Mouse Biliary Tract, J. Comp. Pathol. 94: 263-71).’

 

[JohnDB]

Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna’s COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023 | Moderna, Inc.

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul. 22, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced a new supply agreement with Taiwan for 20 million doses of Moderna’s COVID-19 vaccine and its updated variant booster

investors.modernatx.com

 

[badger2]

A volatile stock with many parameters:

18 Aug 2021 Moderna Stock Slipping Today

Why Moderna Stock Is Slipping Today | The Motley Fool

Booster doses are on the way for more Americans. But it doesn't matter much for Moderna.

www.fool.com

 

[JohnDB]

A volatile stock with many parameters:

18 Aug 2021 Moderna Stock Slipping Today

Why Moderna Stock Is Slipping Today | The Motley Fool

Booster doses are on the way for more Americans. But it doesn't matter much for Moderna.

www.fool.com

Uhhhh...a LOT of stocks have been falling for the past week.
Losers have been more than winners all week.
And where Moderna is a good company it's stock has been ridiculously high in price.

They do have a lot of good drugs in their pipeline there's no way they can produce the earnings needed to back up their current level of capitalization in several years.